A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Authors
Keywords
-
Journal
Cell Reports
Volume 42, Issue 1, Pages 111903
Publisher
Elsevier BV
Online
2022-12-14
DOI
10.1016/j.celrep.2022.111903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
- (2022) Wanwisa Dejnirattisai et al. CELL
- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
- (2022) Zhen Cui et al. CELL
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
- (2022) Kenrie P. Y. Hui et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- (2022) Rigel Suzuki et al. NATURE
- Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
- (2022) Rungtiwa Nutalai et al. CELL
- COVID-19 in 2022—The Beginning of the End or the End of the Beginning?
- (2022) Carlos del Rio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
- (2022) Fritz Obermeyer et al. SCIENCE
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- Monoclonal antibody therapies against SARS-CoV-2
- (2022) Daniele Focosi et al. LANCET INFECTIOUS DISEASES
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- An NTD supersite of attack
- (2021) Shee-Mei Lok Cell Host & Microbe
- A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain
- (2021) Ling Niu et al. Frontiers in Immunology
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Tackling COVID-19 with neutralizing monoclonal antibodies
- (2021) Davide Corti et al. CELL
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
- (2021) Amy Flaxman et al. LANCET
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
- (2021) Jinhui Dong et al. Nature Microbiology
- Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document
- (2021) Alexander L. Greninger et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
- (2021) Yang Liu et al. NATURE
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Coronavirus RNA proofreading: molecular basis and therapeutic targeting
- (2020) Fran Robson et al. MOLECULAR CELL
- Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
- (2020) Jiangdong Huo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
- (2019) Dorothee Liebschner et al. Acta Crystallographica Section D-Structural Biology
- DIALS: implementation and evaluation of a new integration package
- (2018) Graeme Winter et al. Acta Crystallographica Section D-Structural Biology
- Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
- (2017) Alexandra C. Walls et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- xia2: an expert system for macromolecular crystallography data reduction
- (2009) G. Winter JOURNAL OF APPLIED CRYSTALLOGRAPHY
- A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells
- (2008) Joanne E. Nettleship et al. PROTEIN EXPRESSION AND PURIFICATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More